<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00397163</url>
  </required_header>
  <id_info>
    <org_study_id>01/0128</org_study_id>
    <nct_id>NCT00397163</nct_id>
  </id_info>
  <brief_title>Effect of Remote Ischemic Preconditioning in Patient Undergoing Cardiac Bypass Surgery</brief_title>
  <official_title>A Clinical Study Investigating Ischemic Preconditioning in Type II Diabetic Patients Undergoing Coronary Artery Bypass Graft Surgery.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University College London Hospitals</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University College London Hospitals</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      During coronary artery bypass graft surgery, injury occurs to the heart muscle. Some of this
      injury is due to the deprivation of oxygen and nutrients to the heart (a process called
      ischemia) during the surgery itself. The objective of this study is to examine whether remote
      ischaemic preconditioning (RIPC), in which the application of transient ischemia to the
      forearm and thigh (through the inflation of blood pressure cuffs placed on the right upper
      arm and upper thigh) may reduce the injury to the heart muscle sustained during cardiac
      surgery.

      The study hypothesis is: remote ischemic preconditioning will protect the heart and improve
      short-term clinical outcomes during coronary artery bypass graft surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Ischemic heart disease (IHD) is currently the leading cause of morbidity and mortality in the
      developed world, and is set to become the leading cause of death in the world by the year
      2020, according to the World Health Organisation. Patients with severe IHD that require
      coronary artery bypass graft (CABG) surgery, although protected by techniques such as
      cross-clamp fibrillation and cardioplegia, still sustain significant myocardial injury as
      evidenced by perioperative troponin T or I or CK-MB release. Novel treatment strategies are
      required to limit the myocardial injury sustained by patients undergoing CABG surgery in
      order to improve the clinical outcomes of this patient group.

      One such cardioprotective strategy is remote ischemic preconditioning(RIPC) which describes
      the cardioprotection obtained from inducing ischemia in tissue or an organ remote from the
      heart. Our laboratory and others have established RIPC using forearm ischemia (induced by an
      automated cuff applied to the upper arm) as an effective cardioprotective intervention in
      children undergoing corrective cardiac surgery for congenital heart disease and in adults
      undergoing CABG surgery. In this study we investigate whether simultaneous
      inflation/deflation of cuffs placed on the upper arm and thigh can reduce peri-operative
      myocardial injury and improve short-term outcomes in patients undergoing CABG surgery.

      Eligible patients will be those patients undergoing elective CABG surgery who are &gt;18 years
      old, with no significant renal or hepatic disease, and have not had a recent AMI (within 1
      month).

      Consented patients will randomized to RIPC treatment or control.The RIPC protocol will
      comprise simultaneous 2 x 5 minutes of forearm and lower leg ischemia (with an automated
      pressure cuff inflated to 200 mmHg) with an intervening 5 minutes of reperfusion (during
      which the cuff is deflated) between each inflation. The control protocol will comprise a
      deflated cuff being placed on the upper arm and thigh for 20 minutes. The RIPC protocol will
      be implemented after the patients have been anesthetized and immediately prior to CABG
      surgery.

      The measured endpoint of cardioprotection will be troponin-T release at 0, 12, 24, 48 and 72
      hours following CABG surgery.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2010</start_date>
  <completion_date type="Anticipated">November 2019</completion_date>
  <primary_completion_date type="Anticipated">July 2019</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Troponin-T release over the perioperative 72-hour period.</measure>
    <time_frame>3 days</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Coronary Heart Disease</condition>
  <arm_group>
    <arm_group_label>Remote preconditioning</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Simultaneous inflation (5min) and deflation (5min) of cuffs placed on upper arm and thigh - cycle repeated 2 times</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Deflated cuffs placed on upperarm and thigh for 20 minutes</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Remote ischemic preconditioning</intervention_name>
    <description>Blood pressure cuff inflation</description>
    <arm_group_label>Remote preconditioning</arm_group_label>
    <other_name>Remote Ischaemic Preconditioning</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Deflated cuff on upper arm and thigh for 20 min</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>Control</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult patients undergoing elective CABG surgery

        Exclusion Criteria:

          -  &lt;18 years old

          -  Significant renal or hepatic disease

          -  Previous acute myocardial infarction (within 4 weeks)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Derek M Yellon, PhD DSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Hatter Cardiovascular Institute, UCL.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Derek M Yellon, PhD DSc</last_name>
    <phone>+44 203 447 9888</phone>
    <email>d.yellon@ucl.ac.uk</email>
  </overall_contact>
  <location>
    <facility>
      <name>The UCLH Heart Hospital, 14-16 Westmoreland St.</name>
      <address>
        <city>London</city>
        <zip>W1G 8PH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <reference>
    <citation>Kharbanda RK, Li J, Konstantinov IE, Cheung MM, White PA, Frndova H, Stokoe J, Cox P, Vogel M, Van Arsdell G, MacAllister R, Redington AN. Remote ischaemic preconditioning protects against cardiopulmonary bypass-induced tissue injury: a preclinical study. Heart. 2006 Oct;92(10):1506-11. Epub 2006 Jul 3.</citation>
    <PMID>16818489</PMID>
  </reference>
  <reference>
    <citation>Loukogeorgakis SP, Panagiotidou AT, Broadhead MW, Donald A, Deanfield JE, MacAllister RJ. Remote ischemic preconditioning provides early and late protection against endothelial ischemia-reperfusion injury in humans: role of the autonomic nervous system. J Am Coll Cardiol. 2005 Aug 2;46(3):450-6.</citation>
    <PMID>16053957</PMID>
  </reference>
  <reference>
    <citation>Broadhead MW, Kharbanda RK, Peters MJ, MacAllister RJ. KATP channel activation induces ischemic preconditioning of the endothelium in humans in vivo. Circulation. 2004 Oct 12;110(15):2077-82. Epub 2004 Oct 4.</citation>
    <PMID>15466634</PMID>
  </reference>
  <reference>
    <citation>Kharbanda RK, Mortensen UM, White PA, Kristiansen SB, Schmidt MR, Hoschtitzky JA, Vogel M, Sorensen K, Redington AN, MacAllister R. Transient limb ischemia induces remote ischemic preconditioning in vivo. Circulation. 2002 Dec 3;106(23):2881-3.</citation>
    <PMID>12460865</PMID>
  </reference>
  <reference>
    <citation>Kharbanda RK, Peters M, Walton B, Kattenhorn M, Mullen M, Klein N, Vallance P, Deanfield J, MacAllister R. Ischemic preconditioning prevents endothelial injury and systemic neutrophil activation during ischemia-reperfusion in humans in vivo. Circulation. 2001 Mar 27;103(12):1624-30.</citation>
    <PMID>11273988</PMID>
  </reference>
  <reference>
    <citation>Cheung MM, Kharbanda RK, Konstantinov IE, Shimizu M, Frndova H, Li J, Holtby HM, Cox PN, Smallhorn JF, Van Arsdell GS, Redington AN. Randomized controlled trial of the effects of remote ischemic preconditioning on children undergoing cardiac surgery: first clinical application in humans. J Am Coll Cardiol. 2006 Jun 6;47(11):2277-82. Epub 2006 May 15.</citation>
    <PMID>16750696</PMID>
  </reference>
  <reference>
    <citation>Konstantinov IE, Li J, Cheung MM, Shimizu M, Stokoe J, Kharbanda RK, Redington AN. Remote ischemic preconditioning of the recipient reduces myocardial ischemia-reperfusion injury of the denervated donor heart via a Katp channel-dependent mechanism. Transplantation. 2005 Jun 27;79(12):1691-5.</citation>
    <PMID>15973170</PMID>
  </reference>
  <reference>
    <citation>Kristiansen SB, Henning O, Kharbanda RK, Nielsen-Kudsk JE, Schmidt MR, Redington AN, Nielsen TT, Bøtker HE. Remote preconditioning reduces ischemic injury in the explanted heart by a KATP channel-dependent mechanism. Am J Physiol Heart Circ Physiol. 2005 Mar;288(3):H1252-6. Epub 2004 Oct 21.</citation>
    <PMID>15498829</PMID>
  </reference>
  <reference>
    <citation>Konstantinov IE, Arab S, Kharbanda RK, Li J, Cheung MM, Cherepanov V, Downey GP, Liu PP, Cukerman E, Coles JG, Redington AN. The remote ischemic preconditioning stimulus modifies inflammatory gene expression in humans. Physiol Genomics. 2004 Sep 16;19(1):143-50. Epub 2004 Aug 10.</citation>
    <PMID>15304621</PMID>
  </reference>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 6, 2006</study_first_submitted>
  <study_first_submitted_qc>November 7, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 8, 2006</study_first_posted>
  <last_update_submitted>May 3, 2017</last_update_submitted>
  <last_update_submitted_qc>May 3, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 4, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University College London Hospitals</investigator_affiliation>
    <investigator_full_name>Derek Yellon</investigator_full_name>
    <investigator_title>Director of the Hatter Cardiovascular Institute</investigator_title>
  </responsible_party>
  <keyword>Coronary artery bypass graft surgery</keyword>
  <keyword>Remote ischemic preconditioning</keyword>
  <keyword>Troponin-T</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

